Abstract
This study applies patent analysis to discuss the influences of the three aspects of patent trait—a firm’s revealed technology advantage in its most important technological field (RTAMIT), relative patent position in its most important technological field (RPPMIT), and patent share in its most important technological field (PSMIT)—upon corporate growth and discusses the moderation effect of relative growth rate of its most important technological field (RGRMIT) in the American pharmaceutical industry. The results demonstrate that the three relationships between corporate growth and the three aspects of patent trait are positive, and verify that RGRMIT moderates the three relationships. This study suggests that pharmaceutical companies should enhance their R&D capabilities, the degree of leading position, and concentration of R&D investment in their most important technological fields to increase their growth. Finally, this study classifies the pharmaceutical companies into four types, and provides some suggestions to them.
Similar content being viewed by others
References
Barney, J. (1991). Firm resources and sustained competitive advantage. Journal of Management, 17(1), 99–120.
Barney, J., & Hesterly, W. (2009). Strategic management and competitive advantage: Concepts and cases. Upper Saddle River, NJ: Prentice Hall Publisher.
Branch, B. (1973). Research and development and its relation to sales growth. Journal of Economics and Business, 25(2), 107–111.
Breitzman, A., & Thomas, P. (2002). Using patent citation analysis to target/value M&A candidates. Research Technology Management, 45(5), 28–36.
Brockhoff, K. (1991). Competitor technology intelligence in German companies. Industrial Marketing Management, 20, 91–98.
Cardinal, L. B., & Hatfield, D. E. (2000). Internal knowledge generation: The research laboratory and innovative productivity in the pharmaceutical industry. Journal of Engineering & Technology Management, 17, 247–271.
Chen, Y.-S., & Chang, K.-C. (2009). Using neural network to analyze the influence of the patent performance upon the market value of the US pharmaceutical companies. Scientometrics, 80(3), 637–655.
Chen, Y.-S., & Chang, K.-C. (2010a). The relationship between a firm’s patent quality and its market value—the case of US pharmaceutical industry. Technological Forecasting and Social Change, 77(1), 20–33.
Chen, Y.-S., & Chang, K.-C. (2010b). Exploring the nonlinear effects of patent citations, patent share, and relative patent position on market value in the US pharmaceutical industry. Technology Analysis & Strategic Management, 22(2), 153–169.
Chen, Y.-S., & Chang, K.-C. (2010c). The nonlinear nature of the relationships between the patent traits and corporate performance. Scientometrics, 82(1), 201–210.
Chen, Y.-S., & Chang, K.-C. (2010d). Analyzing the nonlinear effects of firm size, profitability, and employee productivity on patent citations of the US pharmaceutical companies by using artificial neural network. Scientometrics, 82(1), 75–82.
Chen, Y.-S., Lin, M.-J. J., & Chang, C.-H. (2006). The influence of intellectual capital on new product development performance—the manufacturing companies of Taiwan as an example. Total Quality Management and Business Excellence, 17(10), 1323–1339.
Deng, Z., Lev, B., & Narin, F. (1999). Science and technology as predictors of stock performance. Financial Analysts Journal, 55, 20–32.
Ernst, H. (1995). Patenting strategies in the German mechanical engineering industry and their relationship to company performance. Technovation, 15(4), 225–240.
Ernst, H. (1998). Patent portfolios for strategic R&D planning. Journal of Engineering and Technology Management, 15, 279–308.
Ernst, H. (1999). Evaluation of dynamic technological developments by means of patent data. In K. Brockhoff, A. K. Chakrabarti, & J. Hauschildt (Eds.), The dynamics of innovation: Strategic and managerial implications. Berlin: Springer Corp.
Ernst, H. (2001). Patent applications and subsequent changes of performance: Evidence from time-series cross-section analyses on the firm level. Research Policy, 30, 143–157.
Ernst, H. (2003). Patent information for strategic technology management. World Patent Information, 25, 233–242.
Feeny, S., & Rogers, M. (2003). Innovation and performance: Benchmarking Australian firms. Australian Economic Review, 36(3), 253–264.
Gebhart, F. (2006). Major drugs lose patent protection in 2006. Drug Topics Supplements, 150, 8–10.
Grabowski, H., & Vernon, J. (1990). A new look at the returns and risks to pharmaceutical R&D. Management Science, 36, 804–821.
Granstrand, O., Patel, P., & Pavitt, K. (1997). Multitechnology corporations: Why they have distributed rather than distinctive core competencies. California Management Review, 39(4), 8–25.
Greene, W. H. (2003). Econometric analysis. Upper Saddle River, NJ: Prentice-Hall Publisher.
Hall, B. H., Jaffe, A., & Trajtenberg, M. (2005). Market value and patent citations. Rand Journal of Economics, 36(1), 16–38.
Henry, G. (2002). Patents, innovation, and access to new pharmaceuticals. Journal of International Economic Law, 5(4), 849–860.
Hoy, F., McDougall, P. P., & Dsouza, D. E. (1992). Strategies and environments of high growth firms. In D. L. Sexton & J. D. Kasarda (Eds.), The state of the art of entrepreneurship. Boston: PWS-Kent Publishing.
Hsiao, C. (1986). Analysis of panel data. Cambridge, UK: Cambridge University Press.
IMS Health. (2010). Global pharmaceutical market growth of 5–7 percent in 2011. Norwalk, CT: IMS Health.
Jensen, E. (1987). Research expenditures and the discovery of new drugs. Journal of Industrial Economics, 36, 83–95.
Johnson, W. H. A. (1999). An integrative taxonomy of intellectual capital: Measuring the stock and flow of intellectual capital components in the firm. International Journal of Technology Management, 18(5–8), 562–575.
Lee, Y. G., Lee, J. D., Song, Y. I., & Lee, S. J. (2007). An in-depth empirical analysis of patent citation counts using zero-inflated count data model: The case of KIST. Scientometrics, 70(1), 27–39.
Levin, R. C., Klevorick, A. K., Nelson, R. R., & Winter, S. G. (1987). Appropriating the returns from industrial research and development. Bookings Paper on Economic Activity, 3, 783–820.
Lin, B., & Chen, J. (2005). Corporate technology portfolios and R&D performance measures: A study of technology intensive firms. R&D Management, 35(2), 157–170.
Maddala, G. S. (1993). The econometrics of panel data. Aldershot: Elgar Publisher.
Mansfield, E. (1986). Patents and innovation: An empirical study. Management Science, 32, 173–181.
Miller, S. M. (1990). The strategic management of technological R&D: An ideal process for the 1990s. International Journal of Technology Management, 5(2), 153–163.
Patel, P., & Pavitt, K. (1997). The technological competency of the world’s largest firms: Complex path-dependent, but not much variety. Research Policy, 26, 141–156.
Pearson, A. E. (2002). Tough-minded ways to get innovative. Harvard Business Review, 80(8), 117–125.
Prahalad, C. K., & Hamel, G. (1990). The core competence of the corporation. Harvard Business Review, 68, 79–91.
Rosenberg, J. B. (1976). Research and market share: A reappraisal of the Schumpeter hypothesis. Journal of Industrial Economics, 25(2), 101–111.
Scherer, F. M. (1965). Corporate inventive output, profits, and growth. Journal of Political Economy, 73(3), 190–197.
Schmookler, J. (1966). Invention and economic growth. Boston: Harvard University Press.
Soete, L., & Wyatt, S. (1983). The use of foreign patenting as an internationally comparable science and technology output indicator. Scientometrics, 5(1), 31–54.
Teece, D. J. (1986). Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy. Research Policy, 15(6), 285–305.
Urabe, K. (1988). Innovation and management: International comparisons. New York: Walter de Gruyter & Co.
U.S. Bureau of Economic Analysis. (2010). Industry economic accounts. Washington, DC: U.S. Bureau of Economic Analysis.
Zahra, S. A., & Bogner, W. C. (1999). Technology strategy and software new ventures’ performance: Exploring the moderating effect of the competitive environment. Journal of Business Venturing, 15(2), 135–173.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, YS. Using patent analysis to explore corporate growth. Scientometrics 88, 433–448 (2011). https://doi.org/10.1007/s11192-011-0396-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11192-011-0396-8